Yanni Zhan

964 total citations
21 papers, 737 citations indexed

About

Yanni Zhan is a scholar working on Pharmacology, Biological Psychiatry and Experimental and Cognitive Psychology. According to data from OpenAlex, Yanni Zhan has authored 21 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 13 papers in Biological Psychiatry and 11 papers in Experimental and Cognitive Psychology. Recurrent topics in Yanni Zhan's work include Treatment of Major Depression (18 papers), Tryptophan and brain disorders (13 papers) and Mental Health Research Topics (9 papers). Yanni Zhan is often cited by papers focused on Treatment of Major Depression (18 papers), Tryptophan and brain disorders (13 papers) and Mental Health Research Topics (9 papers). Yanni Zhan collaborates with scholars based in China, Saudi Arabia and Germany. Yanni Zhan's co-authors include Wei Zheng, Yuping Ning, Yanling Zhou, Lijian Chen, Weijian Liu, Weijian Liu, Hanqiu Li, Xiaofeng Lan, Bin Zhang and Chengyu Wang and has published in prestigious journals such as Cell Death and Differentiation, Journal of Affective Disorders and Psychoneuroendocrinology.

In The Last Decade

Yanni Zhan

21 papers receiving 734 citations

Peers

Yanni Zhan
Silke Conen Netherlands
Angelos Halaris United States
Maura Furey United States
Frank Enning Germany
Myoung-Jin Choi South Korea
Laurence P. Karper United States
Yanni Zhan
Citations per year, relative to Yanni Zhan Yanni Zhan (= 1×) peers Christine Mazzucco

Countries citing papers authored by Yanni Zhan

Since Specialization
Citations

This map shows the geographic impact of Yanni Zhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanni Zhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanni Zhan more than expected).

Fields of papers citing papers by Yanni Zhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanni Zhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanni Zhan. The network helps show where Yanni Zhan may publish in the future.

Co-authorship network of co-authors of Yanni Zhan

This figure shows the co-authorship network connecting the top 25 collaborators of Yanni Zhan. A scholar is included among the top collaborators of Yanni Zhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanni Zhan. Yanni Zhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhuang, Xiaoyin, Yanni Zhan, X Y Feng, & Chaoyuan Liu. (2025). Association between dietary ketogenic ratio and depressive symptoms: A population-based cross-sectional study using 2007–2018 NHANES data. Journal of Affective Disorders. 389. 119652–119652. 1 indexed citations
3.
Zhang, Bin, Chengyu Wang, Wei Zheng, et al.. (2021). Sleep improvement is associated with the antidepressant efficacy of repeated-dose ketamine and serum BDNF levels: a post-hoc analysis. Pharmacological Reports. 73(2). 594–603. 23 indexed citations
4.
Zhan, Yanni, Yanling Zhou, Wei Zheng, et al.. (2021). Working memory associated with anti-suicidal ideation effect of repeated-dose intravenous ketamine in depressed patients. European Archives of Psychiatry and Clinical Neuroscience. 271(3). 431–438. 16 indexed citations
5.
Lan, Xiaofeng, Yanling Zhou, Fengchun Wu, et al.. (2021). The relationship between plasma cytokine levels and antidepressant response in patients with first-episode major depressive disorder. Journal of Affective Disorders. 287. 327–333. 11 indexed citations
6.
Lan, Xiaofeng, Yanling Zhou, Wei Zheng, et al.. (2020). Association between cognition and suicidal ideation in patients with major depressive disorder: A longitudinal study. Journal of Affective Disorders. 272. 146–151. 23 indexed citations
7.
Liu, Weijian, Yanling Zhou, Chengyu Wang, et al.. (2020). Baseline insomnia as a predictor of antidepressant efficacy to repeated intravenous ketamine for unipolar and bipolar depression: A preliminary study. Journal of Affective Disorders. 271. 1–8. 6 indexed citations
8.
Zhou, Yanling, Fengchun Wu, Weijian Liu, et al.. (2020). Volumetric changes in subcortical structures following repeated ketamine treatment in patients with major depressive disorder: a longitudinal analysis. Translational Psychiatry. 10(1). 264–264. 37 indexed citations
9.
Zhan, Yanni, Yanling Zhou, Wei Zheng, et al.. (2020). Alterations of multiple peripheral inflammatory cytokine levels after repeated ketamine infusions in major depressive disorder. Translational Psychiatry. 10(1). 246–246. 52 indexed citations
10.
Zheng, Wei, Yanling Zhou, Weijian Liu, et al.. (2020). A preliminary study of adjunctive ketamine for treatment-resistant bipolar depression. Journal of Affective Disorders. 275. 38–43. 33 indexed citations
11.
Zhou, Yanling, Weijian Liu, Wei Zheng, et al.. (2020). Predictors of response to repeated ketamine infusions in depression with suicidal ideation: An ROC curve analysis. Journal of Affective Disorders. 264. 263–271. 18 indexed citations
12.
Zhan, Yanni, Bin Zhang, Yanling Zhou, et al.. (2019). A preliminary study of anti-suicidal efficacy of repeated ketamine infusions in depression with suicidal ideation. Journal of Affective Disorders. 251. 205–212. 43 indexed citations
13.
Liu, Weijian, Yanling Zhou, Wei Zheng, et al.. (2019). Repeated intravenous infusions of ketamine: Neurocognition in patients with anxious and nonanxious treatment-resistant depression. Journal of Affective Disorders. 259. 1–6. 29 indexed citations
14.
Zhou, Yanling, Wei Zheng, Weijian Liu, et al.. (2018). Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder. Psychoneuroendocrinology. 101. 72–79. 45 indexed citations
15.
Liu, Weijian, Yanling Zhou, Wei Zheng, et al.. (2018). Mediating effect of neurocognition between severity of symptoms and social-occupational function in anxious depression. Journal of Affective Disorders. 246. 667–673. 9 indexed citations
16.
Zheng, Wei, Yanling Zhou, Weijian Liu, et al.. (2018). Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression. Journal of Psychiatric Research. 106. 61–68. 134 indexed citations
17.
Zheng, Wei, Yanling Zhou, Weijian Liu, et al.. (2018). Neurocognitive performance and repeated-dose intravenous ketamine in major depressive disorder. Journal of Affective Disorders. 246. 241–247. 51 indexed citations
18.
Zhou, Yanling, Wei Zheng, Weijian Liu, et al.. (2018). Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression. Brain Behavior and Immunity. 74. 205–212. 70 indexed citations
19.
Zhou, Yanling, Wei Zheng, Weijian Liu, et al.. (2018). Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression. Journal of Psychopharmacology. 32(10). 1118–1126. 55 indexed citations
20.
Zhan, Yanni, et al.. (2004). EDAG regulates the proliferation and differentiation of hematopoietic cells and resists cell apoptosis through the activation of nuclear factor-κB. Cell Death and Differentiation. 11(12). 1299–1308. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026